# Developmental, but not Homeostatic, Collagen V Expression Regulates Mature Murine Supraspinatus Tendon Structure, Function, and Gene Expression

**Authors:** Michael S. DiStefano, Jeremy D. Eekhoff, Stephanie N. Weiss, Courtney A. Nuss, Rebecca L. Betts, Andrew F. Kuntz, Louis J. Soslowsky

PMC · DOI: 10.1002/jor.70164 · Journal of Orthopaedic Research · 2026-02-23

## TL;DR

Collagen V is crucial during tendon development but not in maintaining adult tendon structure and function.

## Contribution

The study shows collagen V's role is critical during development, not in mature tendon homeostasis.

## Key findings

- Developmental collagen V deficiency causes structural and mechanical changes in tendons.
- Reduced collagen V in mature tendons has minimal impact on structure or function.
- Collagen V is essential for region-specific tendon properties during development.

## Abstract

The development of tendon hierarchical structure is dependent on collagen I assembly into fibrils and higher‐order assemblies, a process regulated by interactions involving collagen V, a quantitatively minor yet essential component of the tendon extracellular matrix. Collagen V critically regulates fibrillogenesis and is expressed throughout tendon development and maturation. Clinically, deficiency of collagen V manifests as classic Ehlers‐Danlos syndrome (cEDS), a disorder characterized by hyperextensible skin, joint hypermobility and instability, and impaired wound healing. Recent studies in mouse supraspinatus tendons—which experience complex, region‐dependent loading environments at insertion and midsubstance—demonstrate that developmental collagen V deficiency results in altered tendon structure and biomechanical function. However, differences in structure, mechanics, and gene expression resulting from reduced collagen V expression from embryonic development versus reduction during homeostasis have not been clearly delineated in mature tendons. To address this gap, this study elucidated the role of collagen V on region‐specific tendon structural, functional, and compositional properties in mature, day 150 supraspinatus tendons. Tendon‐targeted Col5a1 deficiency from embryonic development resulted in substantial structural, mechanical, and transcriptional alterations, including disrupted fibril organization, compromised mechanical properties, and altered gene expression profiles. Conversely, acute deficiency and knockdown of Col5a1 in mature tendons resulted in relatively minimal changes. Collectively, these findings identify a distinct and critical role for collagen V during tendon development, rather than homeostasis, in establishing region‐specific multiscale structural, mechanical, and molecular properties essential for mature supraspinatus tendon function.

## Linked entities

- **Genes:** COL5A1 (collagen type V alpha 1 chain) [NCBI Gene 1289]
- **Diseases:** classic Ehlers-Danlos syndrome (MONDO:0007522), cEDS (MONDO:0011804)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Col1a1 (collagen, type I, alpha 1) [NCBI Gene 12842] {aka Col1a-1, Cola-1, Cola1, Mov-13, Mov13}, Mmp13 (matrix metallopeptidase 13) [NCBI Gene 17386] {aka Clg, MMP-13, Mmp1}, Mmp14 (matrix metallopeptidase 14 (membrane-inserted)) [NCBI Gene 17387] {aka MMP-X1, MT-MMP-1, MT1-MMP, sabe}, Lox (lysyl oxidase) [NCBI Gene 16948] {aka TSC-160, rrg}, Loxl2 (lysyl oxidase-like 2) [NCBI Gene 94352] {aka 1110004B06Rik, 4930526G11Rik, 9430067E15Rik}, Bmp4 (bone morphogenetic protein 4) [NCBI Gene 12159] {aka Bmp-4, Bmp2b, Bmp2b-1, Bmp2b1}, Postn (periostin, osteoblast specific factor) [NCBI Gene 50706] {aka A630052E07Rik, OSF-2, Osf2, PLF, PN}, Spp1 (secreted phosphoprotein 1) [NCBI Gene 20750] {aka 2AR, Apl-1, BNSP, BSPI, Bsp, ETA-1}, Igf1 (insulin-like growth factor 1) [NCBI Gene 16000] {aka C730016P09Rik, Igf-1, Igf-I}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Rps17 (ribosomal protein S17) [NCBI Gene 20068], Tgfb1 (transforming growth factor, beta 1) [NCBI Gene 21803] {aka TGF-beta1, TGFbeta1, Tgfb, Tgfb-1}, Loxl1 (lysyl oxidase-like 1) [NCBI Gene 16949] {aka Loxl}, Timp1 (tissue inhibitor of metalloproteinase 1) [NCBI Gene 21857] {aka Clgi, EPA, TIMP-1, TPA-S1, Timp}, Fn1 (fibronectin 1) [NCBI Gene 14268] {aka E330027I09, Fn, Fn-1}, Col5a1 (collagen, type V, alpha 1) [NCBI Gene 12831], Mmp2 (matrix metallopeptidase 2) [NCBI Gene 17390] {aka Clg4a, GelA, MMP-2}, Col3a1 (collagen, type III, alpha 1) [NCBI Gene 12825] {aka Col3a-1, Tsk-2, Tsk2}, Cdh11 (cadherin 11) [NCBI Gene 12552] {aka Cad11, OSF-4}, Lum (lumican) [NCBI Gene 17022] {aka Ldc, SLRR2D}, Ltbp4 (latent transforming growth factor beta binding protein 4) [NCBI Gene 108075] {aka 2310046A13Rik}, Scx (scleraxis scleraxis bHLH transcription factor) [NCBI Gene 20289] {aka Bhlha41, Scl}, Casp3 (caspase 3) [NCBI Gene 12367] {aka A830040C14Rik, AC-3, CASP-3, CC3, CPP-32, CPP32}, Tnc (tenascin C) [NCBI Gene 21923] {aka C130033P17Rik, Hxb, TN, TN-C, Ten, cytotactin}, Aspn (asporin) [NCBI Gene 66695] {aka 4631401G09Rik, Plap1, Slrr1c}, Rn18s (18S ribosomal RNA) [NCBI Gene 19791], Abl1 (Abl proto-oncogene 1, non-receptor tyrosine kinase) [NCBI Gene 11350] {aka Abl, E430008G22Rik, c-Abl}, Vegfb (vascular endothelial growth factor B) [NCBI Gene 22340] {aka VEGF-B, Vrf}, Gt(ROSA)26Sor (gene trap ROSA 26, Philippe Soriano) [NCBI Gene 14910] {aka Gtrgeo26, Gtrosa26, R26, ROSA26, Thumpd3as1}
- **Diseases:** joint hypermobility (MESH:D007593), collagen V deficiency (MESH:D003095), -NULL (MESH:C564833), tendon degeneration (MESH:D052256), patellar tendon injury (MESH:D013708), I-HET (MESH:D006969), skin hyperextensibility (MESH:D012871), inflammation (MESH:D007249), EDS (MESH:D004535), cEDS (MESH:C536194)
- **Chemicals:** paraformaldehyde (MESH:C003043), formalin (MESH:D005557), glutaraldehyde (MESH:D005976), DRAQ5 (-), H&amp;E (MESH:D006371), phosphotungstic acid (MESH:D010772), TRIzol (MESH:C411644), phenol (MESH:D019800), polymethyl methacrylate (MESH:D019904), ethanol (MESH:D000431), calcium chloride (MESH:D002122), osmium tetroxide (MESH:D009993), paraffin (MESH:D010232), cyanoacrylate (MESH:D003487), TM (MESH:D013629), pyridinoline (MESH:C015484), nitrogen (MESH:D009584)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** I-NULL — Homo sapiens (Human), Adult B acute lymphoblastic leukemia, Cancer cell line (CVCL_7960), HET — Homo sapiens (Human), Transformed cell line (CVCL_3702), TEN — Homo sapiens (Human), Endometrial clear cell adenocarcinoma, Cancer cell line (CVCL_E063)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12929041/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12929041/full.md

## References

42 references — full list in the complete paper: https://tomesphere.com/paper/PMC12929041/full.md

---
Source: https://tomesphere.com/paper/PMC12929041